How to Evaluate Microvascular Function and Angina. Myeong-Ho Yoon Ajou University Hospital

Similar documents
Value of Index of Microvascular Resistance (IMR) in Microvascular Integrity

Microvascular Disease: How to Diagnose and What s its Treatment

63 yo woman with chest pain

Hybrid cardiac imaging Advantages, limitations, clinical scenarios and perspectives for the future

Debate Should we use FFR? I will say NO.

Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD

Microvascular disease Prevalence and Management

Aun-Yeong Chong MD, MRCP(UK), MBBS University of Ottawa Heart Institute

IMR in acute STEMI and clinical outcomes

FFR-guided Complete vs. Culprit Only Revascularization in AMI Patients Ki Hong Choi, MD On Behalf of FRAME-AMI Investigators

Calculation of the Index of Microcirculatory Resistance without Coronary Wedge Pressure Measurement in the Presence of Epicardial Stenosis

ABSOLUTE BLOOD FLOW MEASUREMENTS: PRINCIPLES

Fractional Flow Reserve and instantaneous wave -free Ratio. Λάμπρος Κ. Μόσιαλος Επεμβατικός Καρδιολόγος ΓΝ Παπαγεωργίου

Diffuse Disease and Serial Stenoses. Bernard De Bruyne Cardiovascular Center Aalst Belgium

Women and Coronary Artery Disease:

CHRONIC CAD DIAGNOSIS

Pearls & Pitfalls in nuclear cardiology

C. Thrombus burden according to TIMI thrombus grading system

New Insight about FFR and IVUS MLA

PCIs on Intermediate Lesions NCDR Cath-PCI Registry

Physiologic Study Fundamentals, Techniques, and Application

Maria Angela S. Cruz-Anacleto, MD

Fractional Flow Reserve from Coronary CT Angiography (and some neat CT images)

The Future of Coronary Physiology

Between Coronary Angiography and Fractional Flow Reserve

My Patient Needs a Stress Test

Fractional Flow Reserve: Basics, FAME 1, FAME 2. William F. Fearon, MD Associate Professor Stanford University Medical Center

Instantaneous Wave-Free Ratio

Invited Experts' Case Presentation and 5-Slides Focus Review

CASE from South Korea

Fractional Flow Reserve. A physiological approach to guide complex interventions

Detection Of Functional Significance of Coronary Stenoses Using Dynamic. Values Of Myocardial Blood Flow And Coronary Flow Reserve

CT or PET/CT for coronary artery disease

Sung A Chang Department of Internal Medicine, Division of Cardiology, Sungkyunkwan University School of Medicine, Samsung Medical Center

Georgios Pavlakis. Consultant Interventional Cardiologist. K.A.T. General Hospital of Athens, GREECE

Chest Pain in Women ;What is Your Diagnostic Plan? No Need for Noninvasive Test

Microvascular Dysfunction in Takotsubo Cardiomyopathy

FFR Incorporating & Expanding it s use in Clinical Practice

The role of Magnetic Resonance Imaging in the diagnosis of viability & Coronary Artery Disease

Current and Future Imaging Trends in Risk Stratification for CAD

Evidence-Based Management of CAD: Last Decade Trials and Updated Guidelines

Risk Stratification for CAD for the Primary Care Provider

Diffuse Disease and Serial Stenoses

Technical Aspects and Clinical Indications of FFR

Optimal testing for coronary artery disease in symptomatic and asymptomatic patients

Case report. Resistance in the cath lab : the utility of hyperemic stenosis resistance in the functional assessment of coronary artery disease

CLINICAL CONSEQUENCES OF THE

FRACTIONAL FLOW RESERVE: CONCEPT, EXPERIMENTAL BASIS, CUT-OFF VALUES

FFR in diffuse disease and serial stenoses

P F = R. Disorder of the Breast. Approach to the Patient with Chest Pain. Typical Characteristics of Angina Pectoris. Myocardial Ischemia

Evaluation of Intermediate Coronary lesions: Can You Handle the Pressure? Jeffrey A Southard, MD May 4, 2013

Myocardial blood flow PET evaluation and quantification. Dr. Erick Alexánderson. Rosas

EAE Teaching Course. Magnetic Resonance Imaging. Competitive or Complementary? Sofia, Bulgaria, 5-7 April F.E. Rademakers

Conflict of Interest Disclosure

Multisclice CT in combination with functional imaging for CAD. Temporal Resolution. Spatial Resolution. Temporal resolution = ½ of the rotation time

Qualitative and Quantitative Assessment of Perfusion

I have no financial disclosures

Fractional Flow Reserve (FFR) --Practical Set Up Pressure Measurement --

Typical chest pain with normal ECG

SPECT or PET for Cardiovascular Screening in High-Risk Patients

Fractional Flow Reserve (FFR) --Practical Set Up Pressure Measurement --

FFR in Left Main Disease

Myocardial Perfusion: Positron Emission Tomography

The Value of Stress MRI in Evaluation of Myocardial Ischemia

J. Schwitter, MD, FESC Section of Cardiology

A Normal Reference Coronary Flow Reserve is Associated With a Lower Mortality in Patients With Stable Coronary Artery Disease

La FFR quoi d autre: En pratique? Pierre Deharo, CHU TIMONE, Marseille

Atypical pain and normal exercise test

Declaration of conflict of interest. Nothing to disclose

What the Cardiologist needs to know from Medical Images

Old and new insights into viability:perfusion and Perfusion Reserve

Cardiac Viability Testing A Clinical Perspective Annual Cardiac Imaging Symposium. Lisa M Mielniczuk MD FRCPC University of Ottawa Heart Institute

Coronary interventions

ROLE OF CORONARY PRESSURE & FFR IN MULTIVESSEL DISEASE

CMR stress Perfusion: what's new?

Current Guidelines for Diagnosis of AMI Chest pain ST change on EKG Cardiac Enzymes

Control of Myocardial Blood Flow

No-reflow Phenomenon in Patients with Acute Myocardial Infarction: Its Pathophysiology and Clinical Implications

Microvasculature Clinical Importance. Keith G Oldroyd Golden Jubilee National Hospital Glasgow, Scotland

FFR= Qs/Qn. Ohm s law R= P/Q Q=P/R

State of the Art. Advances in Cardiovascular Imaging. ESC Congres Stockholm September 1, 2010 Frank E. Rademakers, MD, PhD, FESC

No-reflow is defined as a failure to restore antegrade normal coronary flow despite appropriate treatment of coronary obstruction. The prevalence of t

Screening for Asymptomatic Coronary Artery Disease: When, How, and Why?

PET myocard perfusion & viability Riemer Slart

Pathophysiology of Coronary Microvascular Dysfunction

Validation of CT Perfusion Imaging Against Invasive Angiography and FFR on a 320-MDCT Scanner

Imaging and heart failure

Metabolic Syndrome Is A Key Determinant Of Coronary Microvascular Function In Patients With Stable Coronary Disease Undergoing PCI

Emerging role of PET in nuclear cardiology. Dr. Erick Alexánderson. Rosas

Patient referral for elective coronary angiography: challenging the current strategy

The Relationship between Microcirculatory Resistance and Fractional Flow Reserve in Patients with Acute Myocardial Infarction

MRI ACS-ben. Tamás Simor MD, PhD, Med Hab. University of Pécs, Heart Institute

The best from Euro-Echo Ischemic heart disease. Fausto Rigo,FESC Department of Cardiology Mestre-Venezia Hospital,Italy

Φαινόμενο No-Reflow. Απεικόνιση με CMR, κλινική συσχέτιση και προγνωστική σημασία

So-Yeon Choi, MD., PhD. Department of Cardiology Ajou University School of Medicine, Korea

Can Angiographic Complete Revascularization Improve Outcomes for Patients with Decreased LV Function? NO!

Imaging in Ischemic Heart Disease: Role of Cardiac MRI

Role of echocardiography in the assessment of ischemic heart disease 분당서울대학교병원윤연이

Which Test When? Avoid the Stress of Stress Testing. Marc Newell, MD, FACC, FSCCT Minneapolis Heart Institute

Original Article. Introduction. Korean Circulation Journal

Transcription:

How to Evaluate Microvascular Function and Angina Myeong-Ho Yoon Ajou University Hospital

Angina without Coronary Artery Disease (CAD) Prevalence: 20-30% going c-angiography, with a higher prevalence (almost 50%) in women. The 5-year rate of MACE outcomes were 3-fold higher in symptomatic women with normal coronary arteries and approximately 8-fold higher in symptomatic women with nonobstructive CAD compared with asymptomatic women without CAD. Gulati M, et al. Arch Intern Med 2009;169:843-50

Angina Pectoris and Myocardial Ischemia Without Obstructive CAD Cardiac syndrome X (CSX) 1) Typical exercise-induced angina 2) Documented stress-induced myocardial ischemia 3) Absence of obstructive atherosclerotic CAD 4) Absence of vasospastic angina Female predominance: 70% of CSX In WISE study, almost half of the women with no obstructive CAD showed abnormal CFR consistent with coronary microvascular dysfunction (CMD)

Angina Pectoris and Myocardial Ischemia in the Absence of Obstructive CAD Microvascular angina 1)+2)+3)+4)+5) Active demonstration of CMD (positive acetylcholine and/or adenosine test results) As many as 50% to 65% of angina patients without obstructive CAD are believed to have CMD, also known as microvascular angina.

Coronary Microvascular Circulation Current cardiovascular imaging technologies are unable to image the vessels that are smaller than 500 m in diameter.

Assessment of Coronary Microvascular Function Study of the coronary microcirculation is indirect parameters, such as coronary blood flow and coronary flow reserve (CFR), which reflect its functional status Lack of uniform diagnostic criteria. Relative contributions of CMD to pathologic microvascular angina are poorly understood yet.

Prognosis of CMD or Microvascular Angina 20% higher rate of cardiovascular events (death, acute coronary syndromes, stroke, and need for revascularization) at 46-month follow-up. Halcox JP, et al. Circulation 2002;106:653 8 Microvascular dysfunction was associated with a 3.3-fold increase in the risk of cardiac death at 12 years (36.9%) compared with subjects having a normal endothelial function. van de Hoef TP, et al. Circ Cardiovasc Interv 2013;6:329 35

F/45, exertional chest pain and dyspnea for 2 years

CFR measured by Flow Wire

Non-Invasive Methods to Assess the Microvascular Function Exercise stress test, exercise treadmill test (ETT): low accuracy, in-sensitive Traditional stress imaging; stress imaging techniques (stress echocardiography, nuclear perfusion stress testing) remain insensitive in diagnosing CMD. Standard noninvasive imaging (stress echo and myocardial perfusion SPECT) is often normal in CMD. Camici PG et al. Circulation 992;86:179-86

Non-Invasive Assessment of Coronary Microcirculation PET (positron emission tomography) scan: - Most established non-invasive technique form the assessment of CBF, regional MBF and reserve

Why PET? - Comparison of PET and SPECT Perfusion Imaging

Diagnostic Accuracy of PET Myocardial Perfusion Imaging Josef M. Nucl Med 2005;35:17-36

Flow Quantification by PET Bengel FM et al. J Am Coll Cardiol 2009;54:1-15

Myocardial Blood Flow And Reserve by PET Provides insight into early and subclinical abnormalities in coronary arterial vascular function and/or structure, non-invasively Predict Prognosis Shindler TH et al. J Am Coll Cardiol 2010;3:623-40

Non-Invasive Assessment of Coronary Microcirculation MRI - Can also be used for quantification of myocardial blood flow

Phase-Contrast Cine MRI RPP (mm Hg/min) = Systolic blood pressure (mm Hg) X Heart rate (beats/min) Corrected coronary sinus flow (ml/min) = coronary sinus flow (ml/min) / RPP (mm Hg/min) X 7500 The CFR were calculated as: CFR = Corrected coronary sinus flow during ATP infusion (ml/min)/corrected coronary sinus flow at rest (ml/min) Kato S et al. J Am Heart Assoc. 2016;5:e002649

Invasive Assessment of CMD TIMI Frame Count and TIMI Frame Count Reserve TIMI Myocardial Perfusion Grade Coronary Reactivity Test Coronary blood flow reserve (CFR) Index of microvascular index (IMR) Hyperemic microvascular resistance index

Coronary Reactivity Test Assessment of endotheliaum-dependent CFR by acetylcholine Assessment of endotheliaum-independent CFR by adenosine A >50% increase in CBF above baseline in response to acetylcholine and a CFR >2.5 in response to adenosine is considered normal.

Corrected TIMI Frame Count First Frame Definition Last Frame Definition Distal Landmark RCA 0 1st branch off posterolateral 5 Frame 0: Dye Touches One or No Borders Frame 21: Dye First Enters Landmark LCX Last branch off most distal OM LAD 10 15 Frame 1: Dye Touches Both Borders & Moves Forward Gibson CM. Circulation 1996; 93:879-888. Whale s tail or pitchfork or most distal branch LAD at apex 21 Normal Flow in the Absence of MI: 21.0 ± 3.1 Frames

Myocardial Blush Following contrast injection into the coronary arteries, there is late filling of the distal capillaries In order to visualize myocardial blush, it is important to remain on the cine pedal for an extended period

TIMI Myocardial Perfusion Grade (TMPG) TMPG 0 No appearance of blush or opacification of the myocardium TMPG 1 Presence of blush but no clearance of contrast (stain is present on the next injection) TMPG 2 Blush clears slowly clears minimally or not at all during three cardiac cycles TMPG 3 Blush begins to washout and is only minimally persistent after three cardiac cycles

TIMI Myocardial Perfusion (TMP) Grades 8 6 4 2 0 TMP Grade 3 Normal ground-glass appearance of blush. Dye mildly persistent at end of washout. P=0.05 2.0% TMP Grade 2 TMP Grade 1 TMP Grade 0 No or minimal blush. Dye strongly persistent at end of washout. Gone by next injection. 4.4% Stain present. Blush persists on next injection. 5.1% 6.2% n=203 n=46 n=79 n=434 Gibson CM, et al. Circulation. 2000;101:125-130

TMPG Simple, however, several limitations Inter- and intraobserver variability Semi-quantitative, subjective Intraobserver variability Interobserver variability Differences N Agreement 1 Grade 2 Grades 3 Grades 40 92.5% 7.5% 0% 0% 40 85.0% 12.5% 2.5% 0% Stone GW, et.al. J Am Coll Cardiol 2002;39:591

CFR by Intracoronary Doppler CFR doppler = hapv/2 X CSA / bapv/2 x CSA = hapv / bapv

CFR by Pressure Wire (Thermodilusion Method) CFR thermo = mean btmn / mean htmn

CMD in Women Without or Non-Obstructive CAD Pepine et al. J Am Coll Cardiol 2010;55:2825-32

Sensitivity Cardiac event free survival (%) CFR After Primary PCI for AMI in Predicting Long-Term MACE 100 1.0 80 0.8 CFR > 1.3 60 40 BCV: 1.3 Sensitivity: 86% Specificity: 70% AUC: 0.80 0.6 0.4 CFR 1.3 20 0.2 p < 0.0001 0 0 20 40 60 80 100 0 0 20 40 60 80 100 120 100-Specificity Months Takahashi T, et al. Am J Cardiol 2007;100:806

Advantages and Limitations of Advantages CFR Concrete Data for microvascular angina Abnormal value between 2.0-2.5 Another factors affecting CFR LVH, LVEDP, HR, Age, Hemodynamic conditions

IMR = P d T mn at maximal hyperemia IMR (Index of Microvascular Resistance) Resistance = Pressure / Flow 1 / T mn Flow IMR = (P d P v ) / (1 / T mn )

Measurement of IMR IMR = 15 U

Case 1 : IMR M/64 STEMI (ant.) IMR : 11.7 U

Case 1 : FDG PET Myocardial viability with FDG PET FDG Uptake = 70.7%

Case 2 : IMR M/60 STEMI (ant.) IMR : 72.3 U

Case 2 : FDG PET Myocardial viability with FDG PET FDG Uptake = 37.4%

Prognostic Value of the IMR The Kaplan Meier curves between IMR >40 and survival free of death or rehospitalization for heart failure. Fearon W et al. Circulation. 2013;127:2436-41

Combined Index (IMR and CFR) in AMI Ahn SG et al. J Am Coll Cardiol Intv 2016;-:- -

IMR (mmhg s) Advantage of IMR Correlation between IMR and TMR at 24 different combinations of myocardial resistance and epicardial stenosis severity 80 70 60 50 40 30 20 10 0 0 0.2 0.4 0.6 0.8 1.0 1.2 1.4 1.6 1.8 TMR (mmhg/ml/min) Aarnoudse et al. Catheter Cardiovasc Interv. 2004;62(1):56-63.

Correlation with base line Advantage of IMR Mean correlation coefficients of IMR, CFR, FFR values comparing baseline measurements with each hemodynamic intervention Repeat baseline / RV pacing at 110 bpm Nitroprusside infusion / dobutamine infusion 1.0 0.8 0.6 0.4 0.2 0.0 IMR CFR FFR Martin et al. Circulation 2006;113;2054-2061

Limitations of IMR Invasive Interpatient variability? Sensor distance (in the distal 2/3 of the vessel) Normal value? No clinical data in patients with angina and nonobstructive CAD Independent of epicardial stenosis Coronary wedge pressure

Hyperemic Microvascular Resistance Index (hmvri) vs. IMR hmvri (mmhg cm sec -1 ) = Pd/hAPV (by Combo Wire) IMR = Pd X Tmn (by Radi Wire)

ComboMap : Pressure and Flow System, Soft ware Version 2.1 3mm

Measurement of hmvri by Combo Wire hmvri hmvri (mmhg cm sec -1 ) = Pd/hAPV = 91/27 = 3.37 mmhg cm sec -1

Sensitivity hmvri and LV-WMA 3.5 3.0 r=0.443, p=0.002 100 hmvri 2.5 80 2.0 1.5 1.0 60 40 BCV: 3.56 Sensitivity: 86.2 Specificity: 57.9 AUC: 0.748 (0.602-0.862).5 20 0.0 0 1 2 3 4 5 6 7 8 0 0 20 40 60 80 100 hmvri (mmhg cm/sec) 100-Specificity Yoon MH, et al. Am J Cardiol 2008;102:129

Kaplan-Meier event free survival analysis for MACE Jin X, et al. Korean Circ J 2015;45:194

Why Should We Measure the Coronary Microvascular Function? Microvascular function is an important prognostic factor in a wide range of disease. In recent years, evidence has shown that CMD is a true clinical entity rather than a mystery or an academic curiosity. Measurement of CMD and identifying the mechanisms of angina is important to provide a rational treatment strategy and improving the quality of life and long-term prognosis.

Thank You for Your Attention